Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
27.33
-0.81 (-2.88%)
At close: Apr 3, 2026
25.94% (1Y)
| Market Cap | 1.55B +23.6% |
| Revenue (ttm) | 174.00M -28.2% |
| Net Income | -49.88M |
| EPS | -0.90 |
| Shares Out | 55.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.34 (1.21%) |
| Ex-Dividend Date | Oct 24, 2025 |
| Volume | 961,254 |
| Average Volume | 884,375 |
| Open | 28.03 |
| Previous Close | 28.14 |
| Day's Range | 26.85 - 28.25 |
| 52-Week Range | 17.50 - 36.00 |
| Beta | 0.40 |
| RSI | 46.72 |
| Earnings Date | Apr 11, 2026 |